Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi confident in case to overturn Praluent ban
BioPharma Dive
Sat, 02/11/17 - 12:47 pm
Tags:
Sanofi, Praluent, Regeneron, Amgen, Repatha
Sanofi, Regeneron win a crucial stay of execution on Praluent
Endpoints
Wed, 02/8/17 - 09:36 pm
Tags:
Sanofi, Regeneron, Praluent, Amgen, Repatha
Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A
Yahoo/Reuters
Wed, 02/8/17 - 09:51 am
Tags:
Sanofi, earnings, M&A
Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit
Yahoo/Reuters
Tue, 01/31/17 - 10:09 am
Tags:
Sanofi, Novo Nordisk, Eli Lilly, price fixing, price collusion, diabetes
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Fierce Pharma
Mon, 01/30/17 - 10:58 pm
Tags:
Sanofi, meningococcal disease, Novartis, vaccines, Menveo, Menactra
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:36 pm
Tags:
Merck, Sanofi, Eli Lilly, Pfizer, Roche, AstraZeneca, Gilead Sciences, Allergan, GSK
Bristol-Myers a takeout target?: 4 plays
CNBC
Tue, 01/24/17 - 10:13 am
Tags:
Bristol-Myers Squibb, M&A, JNJ, Sanofi, Pfizer
Lexicon developing type 1 diabetes treatment with Sanofi
Medical Marketing and Media
Mon, 01/23/17 - 11:17 am
Tags:
Lexicon Pharmaceuticals, Sanofi, drug development, type 1 diabetes
Pharma joins Gates Foundation, international governments in $1B outbreak prep group
Fierce Pharma
Sun, 01/22/17 - 01:43 pm
Tags:
Gates Foundation, GSK, Merck, JNJ, Pfizer, Sanofi, Takeda, R&D, epidemics
Sanofi's M&A misses frustrate some investors in drugmaker
Yahoo/Reuters
Sat, 01/21/17 - 11:34 am
Tags:
Sanofi, M&A
Pfizer signs up for match-making service; Investors tell Sanofi: Make a deal, now
Endpoints
Fri, 01/20/17 - 11:03 am
Tags:
Pfizer, Sanofi, M&A
Sanofi’s Suliqua combination therapy approved in European Union
Mass Device
Wed, 01/18/17 - 03:50 pm
Tags:
Sanofi, Suliqua, Europe, insulin, diabetes, devices
When it comes to PCSK9s, payers resisted — and sales flopped
Medical Marketing and Media
Wed, 01/11/17 - 09:54 am
Tags:
PCSK9 inhibitors, payers, Amgen, Sanofi, Regeneron, Repatha, Praluent
Regeneron CEO says Amgen not putting patients first in patent dispute
Yahoo/Reuters
Tue, 01/10/17 - 09:19 am
Tags:
Regeneron, Pharma CEOs, Amgen, Sanofi, patents, Repatha, Praluent, Len Schleifer
Sanofi Sees No Opening to Actelion Talks After J&J Re-Entry
Bloomberg
Tue, 01/10/17 - 09:08 am
Tags:
Sanofi, Actelion, JNJ, M&A
Judge’s unusual ruling on Amgen, Regeneron patent case puts billions of dollars at stake
Marketwatch
Sun, 01/8/17 - 03:32 pm
Tags:
Amgen, Sanofi, Regeneron, Repatha, Praluent
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection
Yahoo
Fri, 01/6/17 - 10:22 am
Tags:
Regeneron, Sanofi, Amgen, patents, Repatha, Praluent
Amgen Wins Ban on Sanofi’s Praluent Cholesterol Drug Sales
Bloomberg
Fri, 01/6/17 - 09:51 am
Tags:
Amgen, Sanofi, Regeneron, Praluent, Repatha, patents
Endo shakes up marketing, with former Sanofi exec in, recently hired brand chief out
Fierce Pharma
Thu, 01/5/17 - 09:38 am
Tags:
Endo Pharmaceuticals, marketing, Sanofi
Sanofi, Regeneron one step closer to owing PCSK9 royalties as judge upholds Amgen patent ruling
Fierce Pharma
Thu, 01/5/17 - 09:20 am
Tags:
Sanofi, Regeneron, PCSK9 inhibitors, Amgen, Praluent, Repatha

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.